Role of lower genital infection in persistence of Human Papiloma virus infection in wome
Not Applicable
- Conditions
- Health Condition 1: N72- Inflammatory disease of cervix uteri
- Registration Number
- CTRI/2019/03/018191
- Lead Sponsor
- Rajiv Gandhi Institute of Health Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women attending Gynacology opd
Exclusion Criteria
Women on active treatment for pelvic inflammatory disease, abnormal uterine bleeding, tuberculosis, HIV positive, uterovaginal prolapse, post hysterectomy, past history of cryotherapy or other cervical transformation zone excision procedures, any malignancies being treated or to be treated .
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 To identify women with hrHPV(high risk human papilloma virus) by using the hrHPV (high risk human papilloma virus) testing. <br/ ><br>2 To study the patterns and association of cervicovaginal microbiome in the development of hrHPV infection. <br/ ><br>Timepoint: 6-12 months recruitment <br/ ><br>next 12 months follow up. <br/ ><br>total duration 2 years <br/ ><br>
- Secondary Outcome Measures
Name Time Method If chronic cervicitis is associated with persistence of HPV then treatment of chronic cervicits should reduce cervical cancerTimepoint: 2 years